免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Applied Biosystems™ TaqPath™ COVID-19 诊断PCR試劑套件

K 號:K233453 · 2024-07-10

決定日期2024-07-10
產品代碼QQX
諮詢委員會MI (請提供完整的描述文本,以便進行翻譯。)
決定相當於

器材摘要

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is the device name listed in this FDA 510(k) record. The listed applicant is Life Technologies Corporation. It received FDA 510(k) clearance on 2024-07-10 under 510(k) number K233453. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is a medical device that received FDA 510(k) clearance on 2024-07-10. The listed applicant is Life Technologies Corporation. The 510(k) number is K233453.

When did Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit receive FDA 510(k) clearance?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit received FDA 510(k) clearance on 2024-07-10, under 510(k) number K233453.

Who is the listed applicant for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

The FDA 510(k) record lists Life Technologies Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

The FDA product code for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is QQX.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Life Technologies Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:QQX)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑